22NW Fund, LP 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-26 1:20 pm Purchase | 2024-12-23 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 4,367,499 11.100% | 264,278 (+6.44%) | Filing |
| 2024-07-01 4:43 pm Unchanged | 2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 4,103,221 12.400% | 0 (Unchanged) | Filing |
| 2024-06-11 5:27 pm Unchanged | 2024-06-11 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 4,103,221 12.500% | 0 (Unchanged) | Filing |
| 2024-05-20 4:32 pm Purchase | 2024-05-16 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 4,103,221 12.500% | 43,216 (+1.06%) | Filing |
| 2024-02-29 4:25 pm Purchase | 2024-01-06 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 4,060,005 12.440% | 890,068 (+28.08%) | Filing |
| 2024-01-11 4:40 pm Purchase | 2024-01-06 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 4,060,005 12.440% | 4,060,005 (New Position) | Filing |
| 2023-06-28 4:32 pm Purchase | 2023-06-26 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 3,169,937 9.990% | 73,150 (+2.36%) | Filing |
| 2023-01-10 3:46 pm Purchase | 2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 3,096,787 9.990% | 1,341,626 (+76.44%) | Filing |
| 2022-09-12 4:36 pm Purchase | 2022-08-31 | 13G | Lifecore Biomedical, Inc. LFCR | 22NW Fund, LP | 1,755,161 6.000% | 1,755,161 (New Position) | Filing |